Relapsing encephalopathy in a patient with alpha-methylacyl-CoA racemase deficiency.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 18032455.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Alpha-methylacyl-CoA racemase (AMACR) deficiency is a rare disorder of fatty acid metabolism which has recently been described in three adult cases. We have identified a further patient with clinical features of a relapsing encephalopathy, seizures and cognitive decline over a 40 year period. Biochemical studies revealed grossly elevated plasma pristanic acid levels, and a deficiency of AMACR in skin fibroblasts. Sequence analysis of AMACR cDNA identified a homozygous point mutation (c154T>C). This case adds to the phenotypic variation seen in this peroxisomal disorder and highlights the importance of screening for plasma pristanic acid levels in patients with unexplained relapsing encephalopathies.
Medical subject headings
- Brain Diseases, Metabolic, Inborn
- Dementia
- Fatty Acids
- Heredodegenerative Disorders, Nervous System
- Peroxisomal Disorders
- Racemases and Epimerases
- Refsum Disease